Hopkins Study Hints at Role for Next-Gen Methods in Cancer Genome Sequencing; ABI's Agencourt Platform to Be Validated | GenomeWeb
NEW YORK (GenomeWeb News) - Researchers at Johns Hopkins University who published the first cancer sequencing study to validate the concept behind the NIH Cancer Genome Atlas project last week see promise in next-generation sequencing but caution that these methods still have limitations to overcome.   
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.